Impact of SGLT2i on cardiovascular outcomes and heart failure in patients with type 2 diabetes
The concurrent management of type 2 diabetes mellitus and heart failure presents several challenges and unmet clinical needs. The sodium-glucose cotransporter 2 inhibitors (SGLT2i) are new generation of oral hypoglycemic agents, they inhibit renal glucose reabsorption and increase renal glucose excr...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Institute of Mathematical Sciences
2018-01-01
|
| Series: | AIMS Medical Science |
| Subjects: | |
| Online Access: | http://www.aimspress.com/medicalScience/article/1796/fulltext.html |